郑州微飒生物科技有限责任公司 咨询热线:0371-88821766
行业动态

行业动态

追踪行业前沿,洞察产业趋势

药效评价Discovery of novel selective norepinephrine inhibitors: 1-(2-morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-dioxides (WYE-114152).

期刊:Journal of medicinal chemistry发表年份:2011作者:David J O'Neill; Adedayo Adedoyin; Jenifer A Bray; Darlene C Deecher; Andrew Fensome; Joel A Goldberg; Jim Harrison; Liza Leventhal; Charles Mann; Lilly Mark; Lisa Nogle; Nicole R Sullivan; Taylor B Spangler; Eugene A Terefenko; Eugene J Trybulski; A

药效评价Negative cooperativity in binding of muscarinic receptor agonists and GDP as a measure of agonist efficacy.

期刊:British journal of pharmacology发表年份:2011作者:J Jakubík; H Janíčková; E E El-Fakahany; V Doležal

药效评价Combination therapy with paromomycin-associated stearylamine-bearing liposomes cures experimental visceral leishmaniasis through Th1-biased immunomodulation.

期刊:Antimicrobial agents and chemotherapy发表年份:2011作者:Antara Banerjee; Manjarika De; Nahid Ali

药效评价Quantitative pharmacological analysis of antagonist binding kinetics at CRF1 receptors in vitro and in vivo.

期刊:British journal of pharmacology发表年份:2011作者:Simeon J Ramsey; Neil J Attkins; Rebecca Fish; Piet H van der Graaf